Spending on consumer advertising for top-selling prescription drugs in US favors those with low added benefit

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that the share of promotional spending allocated to consumer advertising was on average 14.3 percentage points higher for drugs with low added benefit compared to drugs with high added benefit.

This post was originally published on this site

Skip The Dishes Referral Code